159 related articles for article (PubMed ID: 38638676)
1. A systematic computational analysis of the endosomal recycling pathway in glioblastoma.
Joyce LJ; Lindsay AJ
Biochem Biophys Rep; 2024 Jul; 38():101700. PubMed ID: 38638676
[TBL] [Abstract][Full Text] [Related]
2. Identification of Hypoxia Prognostic Signature in Glioblastoma Multiforme Based on Bulk and Single-Cell RNA-Seq.
Ahmed YB; Ababneh OE; Al-Khalili AA; Serhan A; Hatamleh Z; Ghammaz O; Alkhaldi M; Alomari S
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339384
[TBL] [Abstract][Full Text] [Related]
3. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
[TBL] [Abstract][Full Text] [Related]
4. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
Yang J; Wang L; Xu Z; Wu L; Liu B; Wang J; Tian D; Xiong X; Chen Q
Front Genet; 2020; 11():253. PubMed ID: 32296458
[TBL] [Abstract][Full Text] [Related]
5. Anti-epidermal growth factor receptor therapy for glioblastoma in adults.
Lee A; Arasaratnam M; Chan DLH; Khasraw M; Howell VM; Wheeler H
Cochrane Database Syst Rev; 2020 May; 5(5):CD013238. PubMed ID: 32395825
[TBL] [Abstract][Full Text] [Related]
6. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
Mukherjee S
Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the endosomal recycling pathway downregulates HER2 activation and overcomes resistance to tyrosine kinase inhibitors in HER2-positive breast cancer.
Mishra A; Hourigan D; Lindsay AJ
Cancer Lett; 2022 Mar; 529():153-167. PubMed ID: 35007696
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic insights into super-enhancer-driven genes as prognostic signatures in patients with glioblastoma.
Chen Y; Pan Y; Gao H; Yi Y; Qin S; Ma F; Zhou X; Guan M
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12315-12332. PubMed ID: 37432454
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma.
Dai L; Zhou P; Lyu L; Jiang S
BMC Cancer; 2023 Dec; 23(1):1249. PubMed ID: 38114959
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of single-cell RNA-seq dataset and bulk RNA-seq dataset constructs a prognostic model for predicting survival in human glioblastoma.
Lai W; Li D; Kuang J; Deng L; Lu Q
Brain Behav; 2022 May; 12(5):e2575. PubMed ID: 35429411
[TBL] [Abstract][Full Text] [Related]
12. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
Prasad B; Tian Y; Li X
Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
[TBL] [Abstract][Full Text] [Related]
13. A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme.
Wang Y; Zhao W; Xiao Z; Guan G; Liu X; Zhuang M
J Cell Mol Med; 2020 Apr; 24(7):3807-3821. PubMed ID: 32065482
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
Yin X; Wu Q; Hao Z; Chen L
Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
[TBL] [Abstract][Full Text] [Related]
15. Multi-Omics Data Integration and Mapping of Altered Kinases to Pathways Reveal Gonadotropin Hormone Signaling in Glioblastoma.
Jayaram S; Gupta MK; Raju R; Gautam P; Sirdeshmukh R
OMICS; 2016 Dec; 20(12):736-746. PubMed ID: 27930095
[TBL] [Abstract][Full Text] [Related]
16. Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma.
Cong P; Wu T; Huang X; Liang H; Gao X; Tian L; Li W; Chen A; Wan H; He M; Dai D; Li Z; Xiong L
Front Cell Dev Biol; 2021; 9():709022. PubMed ID: 34589481
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
Patil V; Mahalingam K
Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
[TBL] [Abstract][Full Text] [Related]
18. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
Wei X; Zhang QM; Liu C; Wu S; Nong WX; Ge YY; Lin LN; Li F; Xie XX; Luo B
Curr Med Sci; 2022 Jun; 42(3):584-596. PubMed ID: 35678909
[TBL] [Abstract][Full Text] [Related]
19. A Promising Glycolysis- and Immune-Related Prognostic Signature for Glioblastoma.
Wang F; Liu X; Jiang H; Chen B
World Neurosurg; 2022 May; 161():e363-e375. PubMed ID: 35144031
[TBL] [Abstract][Full Text] [Related]
20. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
